Report Details:
15 Companies Covered
140 Pages
Market Highlights
the Fluoroscopy Mobile C-Arms Market Size was estimated at 2569.4 USD Million in 2024. The Fluoroscopy Mobile C-Arms industry is projected to grow from 2821.35 USD Million in 2025 to 6433.4 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.66% during the forecast period 2025 - 2035.
Fluoroscopy is a medical imaging technique which displays multiple x-rays to generate real-time images or a video of the patient’s body. Fluoroscopy and mobile c-arms systems are used in a broad range of interventional radiological procedures, especially in the treatment of conditions such as spinal cord injury, pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other disease ailments.
The rising prevalence of chronic diseases, growing geriatric population, and rising adoption of fluoroscopy in orthopedic and neurological procedures are some factors propelling the growth of the market. Despite the drivers, the high cost associated with fluoroscopic and mobile c-arm systems, the risk of radiation exposure, and presence of substitutes are some factors that are likely to hinder the growth of the market over the assessment period.
Market Research Future (MRFR) recognizes the following companies as the key players in the global fluoroscopy and c-arms market that includes Allengers Medical Systems (India), Canon Medical Systems Corporation (Japan), DMS Group (France), GE Healthcare (US), Hitachi Ltd (Tokyo), Hologic Inc. (US), Omega Medical Imaging, LLC (US), OrthoScan, Inc. (US), Koninklijke Philips N.V. (The Netherlands), Shimadzu Corporation (Japan), Siemens (Germany), Varian Medical Systems, Inc. (US), Villa Sistemi Medicali Spa (Italy), and Ziehm Imaging GmbH (US).
Segment Analysis
The global fluoroscopy and mobile c-arms market has been segmented into device type, application, and end user. On the basis of device type, the global fluoroscopy and mobile c-arms market has been segmented into fluoroscopy systems and mobile c-arms.
Based on application, the market has been segmented into gastrointestinal, orthopedics, pain management and trauma, cardiovascular, neurology, urology, and others. By end user, the market has been segmented into hospital and clinics, diagnostic centers, research and academic institutes, and others.
Regional Analysis
Geographically, the Americas is expected to dominate the global fluoroscopy and mobile c-arms market. In this region, North America is expected to dominate the market owing to the acceptance of new and innovative products, the growth in awareness about medical imaging devices, and growing financial capability to purchase expensive machines.
Europe showed a significant amount of growth in the market due to the rising incidences of road accidents leading to the increasing number of orthopedic surgeries in the European region, increased expenditure in the healthcare sector, and growing R&D activities.
Asia-Pacific is estimated to be the fastest growing region in the market. The developing economies of China, India, and South Korea are emerging as major destinations for outsourcing clinical trials and pathology testing. Furthermore, the Middle East & Africa has the least share of the global fluoroscopy and mobile c-arms market due to the low disposable income and poor healthcare infrastructure.
Key Findings of the Study
- Technological advancements are enhancing imaging capabilities, thereby improving diagnostic accuracy.
- The demand for minimally invasive procedures is rising, particularly in the orthopedic surgery segment, which remains the largest market.
- North America continues to dominate the market, while the Asia-Pacific region is emerging as the fastest-growing area for fluoroscopy mobile C-arms.
- Key market drivers include the growing geriatric population and the expansion of healthcare infrastructure, which support the rising preference for cost-effective solutions.
